An extremely important message from Dr. Terry Chappell

The Trial to Assess Chelation Therapy (TACT) showed statistically significant benefits for patients with heart disease at the American Heart Association meeting on November 4, 2012.  Despite the cautionary statements by the investigators, and the reluctance from the critics, the results stand by themselves.  This is the first major randomized clinical trial on chelation for vascular disease, and it is a positive study(1,2).
This message is not meant for publication because TACT has not yet been published in a scientific journal.  However, I cannot wait to share with our patients and friends what TACT and previous studies(3) mean to current medical science and to those who could benefit from them.
If you are a diabetic, even if you are well controlled, TACT shows that chelation might reduce your need for cardiac surgery by 39% more than standard cardiac care.  Our experience is that chelation can reduce your chances for blindness, kidney failure, amputation and other vascular complications of diabetes.  I believe that ALL diabetics should take chelation, starting about age 30.
If you have hypertension or vascular disease, even if you are well controlled, you are likely to have high lead levels in your body(4).  There are indications that lead might increase the risk of premature death, heart disease, Alzheimer’s disease, strokes, cancer, and autoimmune disease(5).  Chelation removes lead from the body.  You should be tested for lead with a “challenge” test.  If you have lead present, you should take a basic course and maintenance chelation to help prevent these diseases and complications.
Many people have mild to moderate kidney disease, as measured by a creatinine clearance test.  Most doctors just monitor this problem because they have no treatment for it other than strict blood pressure control.  Mild kidney failure can lead to eventual dialysis.  Chelation has been shown to improve kidney function in patients with kidney disease(6).  Anyone over the age of 50 should be tested.  If there is even a slight decrease in kidney function, chelation should be offered.  It might save a life.
If you believe in prevention of these common diseases, you should eat healthy, exercise regularly, minimize stress, and avoid cigarette smoke.  And you should take intravenous chelation therapy because it can reduce the chances of developing these common health problems before they start to attack your body.
I believe that chelation is the most powerful prevention intervention that we have(7).  Everyone should take it to improve his or her chances for living a disease-free life.  Scientific evidence is accumulating to back me up.  Celebration of Health Association is one of the premier centers in the world that offers chelation therapy.  Take advantage of what we have to offer.  You now know what you should know to save your life and the lives of your friends and relatives.
You do not have to be a doctor, nurse or paramedic to save lives.  Just share the vital information contained in this message with others.  Bring them to our clinic.   Or ask them to set up a free phone consultation with me (Dr. Chappell) to discuss whether we can be of help.  See to it that they know what they should know so that they can save their lives too!

Chelation is not just a treatment that is slowly emerging into the spotlight.  It is a movement against the forces that are resisting change, especially from powerful economic interests.  You should reap the benefits yourself, but you should also take responsibility to share them with others.
TACT is the breakthrough study we needed.  More studies will follow, but that will take years.  Cardiologists and other critics will be convinced eventually, but we want to help people now.  Join the movement. Spread the word.  Let us help you, your friends, and your relatives when the need is greatest, which is right now.
Thanks for your concerns, support, efforts, and prayers.  We would not exist without them.

    Terry Chappell, M.D.
    Offices in Bluffton, Ohio and Toledo

1. http:www.globenewswire.com/news-release/2012/11/5/502198/10011031/en/Alternative-Therapy-Produces-Intriguing-Results-in-Some-Heart-Patients-but-Many-Questions-Remain.
2. Lamas GA, Goertz C, Boineau R, Mark DB, Rozema T, Nahin RL, Drisko JA, Lee KL.  Design of the Trial to Assess Chelation Therapy (TACT).  Am Heart J 2012;163:7-12.
3. Chappell LT, Shukla R, Yang J, Blaha R, Born T, Hanke C, Mitchell W, Olszewer E, van der Schaar P, Ventresco J.  Subsequent cardiac and stroke events in patients with known vascular disease treated with EDTA chelation therapy: a retrospective study.  Evid Based Integrative Med 2005;2:27-35.
4. Nash D, Magder L, Lustberg M, et.al.  Blood lead, blood pressure, and hypertension in perimenopausal and post menopausal women.  JAMA 2003;289:1523-32.
5. Menke A, Muntner P, Batuman V, Silberbeld EK, et.al.  Blood lead below 0.48 micromol/L(10 microg/dl) and mortality.  Circulation 2006;114:1388-94.
6. Lin JL, Lin-Tan DT, Hsu KH, et.al.  Environmental lead exposure and progression of renal diseases in patients without diabetes. N Engl J Med 2003;348:277-86.
7. Cranton EM, Frackelton JP.  Free radical pathology on age-associated diseases; treatment with EDTA chelation, nutrition and antioxidants. J Holist Med 1984;6:6-37.

This message is my opinion.  It is not meant to be medical advice to any specific patient.  You should always consult with your physician(s) before undergoing any medical treatment.

The information on this website is only the opinion of COHA. It is not meant to be medical advice. Before you do anything, you should seek the advice of your personal physician. This is information only. No treatment is proposed, no cure is implied, and no claim is made for the effectiveness of any treatment or test.

© 2016 by Celebration of Health Association